CardioVascular Resource Group, LLC

🚨 CardioVascular Resource Group is heading to Kidney Week in San Diego, CA on Oct 24-27! 🚨 Our expert team will be on-site evaluating and analyzing the latest groundbreaking data at #ASN24. Stay ahead in the broad and diverse renal landscape with CVrg’s insights! 🔎 Want a sneak peek? Contact Brooke Blackwelder or Kerry Southworth for a complimentary copy of CVrg’s ASN Congress itinerary. It’s one of the many ways CVrg distills complex information to uncover key trends and opportunities. #KidneyWeek2024 #KidneyWk #ASN2024 #IgAN #Nephrology #KidneyCare #kidneydisease

🚨 CardioVascular Resource Group is heading to Kidney Week in San Diego, CA on Oct 24-27! 🚨 Our expert team will be on-site evaluating and analyzing the latest groundbreaking data at #ASN24. Stay ahead in the broad and diverse renal landscape with CVrg’s insights! 🔎 Want a sneak peek? Contact Brooke Blackwelder or Kerry Southworth for a complimentary copy of CVrg’s ASN Congress itinerary. It’s one of the many ways CVrg distills complex information to uncover key trends and opportunities. #KidneyWeek2024 #KidneyWk #ASN2024 #IgAN #Nephrology #KidneyCare #kidneydisease

September 29th marks World Heart Day, a global campaign to raise awareness about cardiovascular disease (CVD) and its prevention. As the world’s leading cause of death, accounting for 32% of all global deaths in 2019, CVD remains a pressing concern that needs immediate attention. CVrg fully supports heart health by providing comprehensive overviews and deep-dive reports to assist Biopharma's efforts to tackle CVD risk and treatment across the spectrum of cardiometabolic diseases.  Reach out to Kerry Southworth to learn more about CVrg's cardiovascular coverage. #WorldHeartDay #cardiovascular #HeartHealth #competitivestrategy #AHA24

CardioVascular Resource Group is looking forward to another jam-packed ESC Congress and will be on the ground in London to absorb and analyze the newest data. Contact Kerry Southworth for a complimentary copy of CVrg’s ESC Congress planner and discover one of the many ways CVrg cuts through the fog of information to reveal the dynamic cardiovascular-metabolic landscape. #ESCCongress #cardiovascular #metabolic #competitiveintelligence #competitivestrategy #pharmaCI #finerenone #fineartshf #plozasiran

CVrg's metabolic team, led by Liz Poyner PhD CChem FRSC, is evaluating groundbreaking new data at this year's ADA. If you're interested to learn more about CVrg's conference coverage, reach out to Brooke Blackwelder for details. #diabetes #ADA #ada2024 #competitiveintelligence #pharmaCI

The CVrg CKD team is excited to capture the new renal data at ERA 2024 in Stockholm! Curious about our conference plans for the rest of 2024? Reach out to Brooke Blackwelder for details into how CVrg can support your needs! Let's navigate the kidney disease landscape together. #ERA24 #CKD #metabolic #kidney #competitivestrategy

I'll be listening in to late-breaking data from #HeartFailure2024 on Saturday.

CVrg is poised to evaluate the newest data at the premier heart failure-focused conference of the year, the ESC's Heart Failure Congress in Lisbon, Portugal. CVrg's HF lead Matt Racine, Ph.D. is particularly looking forward to the readout for the SEQUOIA-HCM trial of aficamten in patients with obstructive hypertrophic cardiomyopathy, amongst other abstracts. If you want to stay "in the know" about hot heart failure data and how they fit into the larger HF landscape, contact Brooke Blackwelder for more information about CVrg's HF-ESC 2024 coverage and other HF reports. #HeartFailure2024 #cardiovascular #competitivestrategy

I'm looking forward to news from #ATS2024! 💙

💙 Join CVrg as we advocate for improved access to diagnosis, treatment, and care worldwide, for Pulmonary Hypertension, starting on World PH Day, May 5th. We're thrilled about the recent approval of two new drug therapies for US PAH patients in March, but the journey doesn't end there. We eagerly anticipate future advancements in PAH treatment and look forward to a day when all PH WHO Groups can benefit from approved therapies. CVrg is addressing this issue by providing crucial scientifically-based clinical and commercial strategy support to biopharma developers. Connect with Brooke Blackwelder to learn more about our coverage of ATS 2024. Join us in raising awareness and taking action! #WorldPHDay #PHAwareness #ATS2024 #cardiovascular